|Bid||145.000 x 100|
|Ask||145.220 x 100|
|Day's Range||144.204 - 145.210|
|52 Week Range||95.140 - 147.450|
|PE Ratio (TTM)||123.86|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Illinois-based global medical device company Abbott Laboratories (ABT) partnered with Bigfoot Biomedical to solidify its footprint in the rapidly growing diabetes therapeutics market.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABIOMED, Inc. Here are 5 ETFs with the largest exposure to ABMD-US. Comparing the performance and risk of ABIOMED, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
With solid growth prospects Abiomed (ABMD) carries a Zacks Rank #1 (Strong Buy) which is an attractive pick at present.